Related Experiment Video
Updated: Aug 9, 2026
Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Calcium channel blockers in hypertension. Is there still a controversy?
1Clinical Pharmacology Division, Department of Medicine, State University of New York at Buffalo, Buffalo, USA. Jizzo@ams.ecmc.edu
Insights
No single high blood pressure medication works best for everyone due to patient differences and the need for combination therapy. Calcium channel blockers (CCBs) are effective, especially with other drugs, for managing hypertension and its complications.
Area of Science:
- Cardiology
- Pharmacology
- Nephrology
Background:
- Hypertension management is complex due to patient heterogeneity and drug mechanisms.
- Achieving sustained blood pressure control often necessitates combination therapy.
- Specific antihypertensive drug classes are crucial for managing hypertension complications.
Purpose of the Study:
- To evaluate the role of calcium channel blockers (CCBs) in hypertension treatment.
- To discuss the optimal use of CCBs in combination therapy for diverse patient populations.
- To address controversies surrounding CCB use in specific conditions like heart failure and kidney disease.
Main Methods:
- Review of existing literature on antihypertensive drug classes and their efficacy.
- Analysis of pathophysiologic factors influencing hypertension treatment outcomes.
- Examination of clinical guidelines and evidence for CCB use in various comorbidities.
Main Results:
- Calcium channel blockers (CCBs) demonstrate significant efficacy in lowering blood pressure and preventing cardiovascular events.
- CCBs are valuable additions to therapy, even in heart failure and chronic kidney disease, for achieving target blood pressure.
- Combination therapy, particularly CCBs with ACE inhibitors, improves blood pressure control and reduces adverse effects like edema.
Conclusions:
- The ideal antihypertensive regimen is individualized, often requiring combination therapy.
- Calcium channel blockers (CCBs) are a cornerstone in managing hypertension and its complications.
- Strategic combination of CCBs with other agents ensures effective and safe blood pressure management.
Abstract:
There are several reasons why no single antihypertensive drug class is ideal in all clinical situations. First, pathophysiologic heterogeneity in hypertension and diversity of mechanisms of antihypertensive drugs dictate that no single drug class can be optimally effective in all subpopulations. Second, sustained blood pressure control generally requires combination therapy to block the reflex stimulation of physiologic mechanisms that attempt to restore blood pressure to pretreatment levels. Third, while effective blood pressure control is more important than choice of initial drug in the prevention of hypertension-related morbidity and mortality, specific drug classes are indicated for optimal treatment of complications of hypertension (e.g. heart failure, kidney disease). Fourth, although antihypertensive drug side effects are uncommon, alternative strategies are required in some patients. Given these principles, past controversies regarding whether calcium channel blockers (CCBs) should be used in the treatment of hypertension become moot. CCBs are extremely effective in lowering blood pressure and in preventing stroke and cardiovascular disease. When additional blood pressure lowering is necessary to meet strict targets, CCBs may be added, even in heart failure or chronic kidney disease, where CCBs alone may not achieve optimal outcomes. Combinations of CCBs with "anti-neurohumoral" drugs such as ACE inhibitors are particularly useful to achieve sustained blood pressure control, reduce adverse effects such as edema, and improve outcomes.
Related Concept Videos
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications